Intelligence Hub
Market analytics and operational performance indicators
Insider Trading - November 26, 2025
SVP Kampani sold 10,554 shares (~$445K) via 10b5-1 plan.
Brief
Arjun Kampani, SVP General Counsel of Rocket Lab USA, sold 10,554 shares on 11/26/2025 at weighted average prices of $41.96 and $43.16. The sales were automatic under a Rule 10b5-1 trading plan adopted on December 12, 2024. This is a neutral signal as it is a pre-scheduled disposition not reflecting current market views.
Detailed Brief
Arjun Kampani, Senior Vice President, General Counsel of Rocket Lab USA Inc. (RKLB), reported selling 9,506 shares at a weighted average price of $41.9641 (range $41.46-$42.24) and 1,048 shares at $43.1576 (range $42.82-$43.40), totaling 10,554 shares for approximately $445,000 on November 26, 2025. Post-transaction, he beneficially owns 450,460 shares directly. The transaction was executed automatically pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024, as indicated by the checked box on the Form 4. No derivative securities were involved, and this appears to be a routine scheduled sale with no indication of discretionary timing or clustering with other insiders. Historical pattern not specified in filing, but 10b5-1 plans mitigate concerns over insider timing.
Key Telemetry
- • Sold 10,554 shares (2.3% of post-sale holdings of 450,460 shares)
- • Executed under pre-existing 10b5-1 plan from Dec 2024 (routine, non-discretionary)
- • Sale prices ~$42-$43; no context on 52-week range or earnings proximity provided
- • First reported trade in recent period? No prior pattern detailed
Risk Signals
Impact Vector
This 10b5-1 plan sale is neutral, indicating no change in insider confidence as it was pre-scheduled without discretion. It does not signal bullish or bearish sentiment.